Seoul Pharma Co., Ltd (KOSDAQ:018680)
2,725.00
-5.00 (-0.18%)
At close: May 8, 2026
Seoul Pharma Market Cap
Seoul Pharma has a market cap or net worth of 30.31 billion as of May 11, 2026. Its market cap has decreased by -15.17% in one year.
Market Cap
30.31B
Enterprise Value
37.76B
Revenue
52.15B
Ranking
n/a
PE Ratio
40.22
Stock Price
2,725.00
Market Cap Chart
Since March 1, 2001, Seoul Pharma's market cap has increased from 20.00B to 30.31B, an increase of 51.57%. That is a compound annual growth rate of 1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 30.31B | -15.58% |
| Dec 30, 2025 | 35.91B | -6.95% |
| Dec 30, 2024 | 38.59B | -13.58% |
| Dec 28, 2023 | 44.66B | -23.86% |
| Dec 29, 2022 | 58.65B | -12.36% |
| Dec 30, 2021 | 66.92B | -28.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eagle Veterinary Technology Co.,Ltd | 48.61B |
| Korean Drug | 42.07B |
| HLscience | 42.02B |
| GeneBioTech Co. ,Ltd | 37.37B |
| Baskhanbio Pharma | 35.06B |
| Pharmsville | 27.51B |
| ChoA Pharmaceutical Co., LTD. | 27.42B |
| Daesung Microbiological Labs. | 25.73B |